Europe

Mon
27
Jan

Will medical cannabis soon be part of the European Single Market?

Prior to discussing the recent legal developments in the field of medical cannabis, it is important to distinguish between medical cannabis and EU-approved medicinal products derived from cannabis. Medical cannabis is cannabis grown for medical purposes, whereas EU-approved medicinal products encompass certain medicines derived from cannabis and containing an amount of the active ingredients of cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). The EU has approved some medicinal products derived from cannabis but has not yet approved medical cannabis itself as a medicinal product.

Tue
21
Jan

Europe needs time to warm to cannabis, but hope is slow and steady wins the race

When it comes to exporting marijuana to Europe, the North American model might need a little work.

The pace with which cannabis legalization is advancing across Canada and the U.S. — often ahead of needed regulations — does not work on a continent that literally speaks different languages, according to Strain Insider. As markets encounter turmoil here, armchair analysts may not have the answers they think they do to problems across the pond where business can move much more slowly.

Fri
17
Jan

The CBD craze is about to roll over Europe

While CBD seems to be everywhere and do everything in North America, from treating anxiety disorders in pets to putting the glow back in your complexion, in Europe, it is just hitting the radar.

That’s probably because the legal framework in Europe surrounding CBD is so confusing. Each country in the European Union (EU) has different laws for CBD, despite the fact that they share the EU umbrella. Strain Insider has reported that the regulations between countries can be tricky.

Thu
16
Jan

London professor appointed chairman of Europe medicinal cannabis body

A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European Medicinal Cannabis Association.

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman.

Fri
10
Jan

First medical cannabis Exchange Traded Fund in Europe launched

The Medical Cannabis and Wellness UCITS ETF (CBDX) is the first medical cannabis Exchange Traded Fund to be listed in Europe.

European company, HANetf, has announced that Canadian based asset manager, Purpose Investments, has launched its first UCITS Exchange Traded Fund (ETF) through HANetf’s unique white-label ETF platform – The Medical Cannabis and Wellness UCITS ETF (CBDX).

Mon
30
Dec

What is stopping medical cannabis from being accepted in the UK?

Following extensive public awareness campaigns and increased media pressure on the healthcare system, the legalisation of medical cannabis in November 2018 was hailed a monumental victory among clinicians and patients alike.

Fri
27
Dec

Advice from the experts: communication is key for the cannabis industry

FTI Consulting provide their clients across Germany with expert advice in strategic communications, corporate finance and restructuring, construction solutions and competition economics including the cannabis industry.

For more than 15 years, their strategic communications practice has advised clients – ranging from German Mittelstand to global corporations – in all aspects of their communications activities. They advise on financial, regulatory and reputational issues, and provide capital markets communications; corporate, brand, change, crisis and internal communications; and public affairs advice.

Wed
18
Dec

German Medical Cannabis – A Model For Europe, As Prices Fall

The success of the robust German medical cannabis program is an example for the rest of Europe, claims a newly-formed lobby group.

As patients in other European jurisdictions struggle to access cannabis medicine, Germany is leading the way with over 142,000 prescriptions written in 2018. It is also leading the way in cutting prices with a new wholesale prices of 2.3 euros per gram set to substantially reduce the current cost of medical cannabis, reports the Mjbizdaily website.

Tue
17
Dec

New Research Highlights Europe’s Glaring CBD Differences

The French are the most skeptical of CBD whilst their Swiss neighbors are the most engaged, new European research has revealed.

Mon
16
Dec

5 Cannabis Stocks That Could Capitalize On The Booming EU Cannabis Sector

Read entire article here.

During the last year, the cannabis sector has been in the middle of a major transition that has been centered around the expansion into new markets. The European Union (EU) has been a point of emphasis for these cannabis operators and we are favorably on this strategy for growth.

When compared to the Canadian and US cannabis markets, the opportunity in the EU is much less saturated and is in the early innings of a major growth cycle. Currently, the production of cannabis is not allowed in most of Europe and the product is imported from either Canada or the Netherlands.

Pages

Subscribe to RSS - Europe